238 related articles for article (PubMed ID: 24633144)
1. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.
Beaber EF; Malone KE; Tang MT; Barlow WE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):755-64. PubMed ID: 24633144
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
3. Use of oral contraceptives and risk of breast cancer in young women.
Ursin G; Ross RK; Sullivan-Halley J; Hanisch R; Henderson B; Bernstein L
Breast Cancer Res Treat; 1998 Jul; 50(2):175-84. PubMed ID: 9822222
[TBL] [Abstract][Full Text] [Related]
4. A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium.
Bethea TN; Rosenberg L; Hong CC; Troester MA; Lunetta KL; Bandera EV; Schedin P; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res; 2015 Feb; 17(1):22. PubMed ID: 25849024
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and breast cancer.
Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive agents and breast cancer: a population-based case-control study.
Rohan TE; McMichael AJ
Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
[TBL] [Abstract][Full Text] [Related]
8. Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer.
Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI
Horm Cancer; 2019 Jun; 10(2-3):71-76. PubMed ID: 30989580
[TBL] [Abstract][Full Text] [Related]
9. Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.
Beaber EF; Buist DS; Barlow WE; Malone KE; Reed SD; Li CI
Cancer Res; 2014 Aug; 74(15):4078-89. PubMed ID: 25085875
[TBL] [Abstract][Full Text] [Related]
10. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.
Kawai M; Malone KE; Tang MT; Li CI
Cancer; 2014 Apr; 120(7):1026-34. PubMed ID: 24515648
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for triple-negative breast cancer in women under the age of 45 years.
Dolle JM; Daling JR; White E; Brinton LA; Doody DR; Porter PL; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1157-66. PubMed ID: 19336554
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
14. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.
Kawai M; Malone KE; Tang MT; Li CI
Cancer; 2014 May; 120(10):1548-56. PubMed ID: 24500704
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
17. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
19. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
[TBL] [Abstract][Full Text] [Related]
20. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
